Results 321 to 330 of about 304,363 (385)

M6A-dependent RNA condensation underlies FUS autoregulation and can be harnessed for ALS therapy development. [PDF]

open access: yesSci Adv
Huang WP   +13 more
europepmc   +1 more source

Genome‐wide analysis of somatic noncoding mutation patterns and mitochondrial heteroplasmic shift in type B1 and B2 thymomas

open access: yesThe Journal of Pathology, EarlyView.
Abstract Type B1 and B2 thymomas are lymphocyte‐rich malignant tumours with few somatic mutations in protein‐coding regions of the nuclear genome; nonetheless, noncoding regions remain uncharacterized. Here, we developed a method to isolate pure thymoma cells from lymphocyte‐rich tissues, and then performed genome‐wide deep sequencing. The total number
Kohei Fujikura   +10 more
wiley   +1 more source

Generation of functional noncanonical donor splice sites by +2T variants in breast cancer susceptibility genes: impact on clinical interpretation

open access: yesThe Journal of Pathology, EarlyView.
Abstract Splicing dysregulation is a relevant mechanism of pathogenicity for variants in disease susceptibility genes. Variants affecting the critical intronic +1 and +2 GT nucleotides of the 5’ splice sites (5'ss) are generally strong indicators of pathogenicity.
Inés Llinares‐Burguet   +7 more
wiley   +1 more source

RNA <i>trans</i>-splicing to rescue β-catenin: A novel approach for treating CTNNB1-Haploinsufficiency disorder. [PDF]

open access: yesMol Ther Nucleic Acids
Maruna M   +4 more
europepmc   +1 more source

Interactive Bioinformatics Lab: Using Genomic Databases for Active Learning in Dentistry

open access: yes
Journal of Dental Education, EarlyView.
François Isnaldo Dias Caldeira   +1 more
wiley   +1 more source

Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International Cohorts

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Hemophilia A (HA) is a rare bleeding disorder caused by coagulation factor VIII (FVIII) deficiency. Prophylactic FVIII replacement therapy is essential for preventing bleeds, but it carries a risk of inhibitor development, especially in previously untreated and minimally treated patients (PUPs and MTPs, respectively).
Sarina Levy‐Mendelovich   +11 more
wiley   +1 more source

Inhibition of PfCLK3 a master regulator of malaria parasite RNA-splicing provides the basis for a radical cure for malaria

open access: yes
Janha O   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy